Followers | 35 |
Posts | 6308 |
Boards Moderated | 0 |
Alias Born | 02/09/2015 |
Tuesday, February 09, 2016 6:46:00 PM
It is a good question. Look, Vancomycin presents so many hassles that all of those who prescribe it would rather write an order for another drug. I think Brilacidin should be able to replace it for many reasons already talked about on the board
What will happen if there is a cheap generic alternative Daptomycin, when it goes off patent? How much more attractive will Brilacidin be than such a drug? It depends on what exactly the competition is when Brilacidin becomes available.
One of the most interesting parts of the recent interview with Leo was the discussion about the government holding B in reserve, and not using it. You could really almost hear the conversation leo may or may not have had with the FDA and government officials.
What about a completely new class of drugs? Shouldn't we use the other drugs until we can no longer use them? What is the role of antibiotic stewardship? So far no resistance, but does anyone really belive that no resistance will ever develop? Who knows?
Leo is rehearsing future conversations with the FDA or repeating discussions he has already had, or Jorgensen has had, or whoever their best antibiotic spokesman is.
Brilacidin when it is approved-obv I hope it is a when and not an if- will be a VERY BIG deal, because it is as we all know, a whole new type of antibiotic. I think there will be a lot of discussion as to its proper role, and whether to reserve its use, and I anticipate a real serious conversation about all of these issues
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM